| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 02/02/2005 | EP1501351A2 Short fragment homologous replacement to provide bse resistant cattle |
| 02/02/2005 | EP1281078A4 Methods for screening and identifying host pathogen defense genes |
| 02/02/2005 | EP1064394B1 Method for ballistic transformation of caenorhabditis elegans |
| 02/02/2005 | EP0741788B1 Inducing tolerance with tolerogenic fusion proteins |
| 02/02/2005 | CN1575343A Method for identifying fast-growing fish in different salinity |
| 02/02/2005 | CN1575301A Administration of nucleic acid sequence to female animal |
| 02/02/2005 | CN1572876A Glyt1 conditional knock-out mice |
| 02/02/2005 | CN1187450C Method for producing transgenic non-human mammal |
| 02/01/2005 | US6849717 Polycystic kidney disease gene homologs required for male mating behavior in nematodes and assays based thereon |
| 02/01/2005 | US6849413 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders |
| 01/27/2005 | WO2005007877A2 Regulatable promoters for synthesis of small hairpin rna |
| 01/27/2005 | WO2005007845A2 Transgenic cells |
| 01/27/2005 | WO2004082517A3 Animal exhibiting ptsd-like behavior, per pct rule 4.3 |
| 01/27/2005 | WO2004074514A3 Method of diagnosis of type 2 diabetes and early onset thereof |
| 01/27/2005 | WO2004067707A3 Administration of transposon-based vectors to reproductive organs |
| 01/27/2005 | WO2004060053A3 Transgenic mice expressing human cd20 |
| 01/27/2005 | WO2004053090A3 Method and system for utilizing somatic cell nuclear transfer embryos as cell donors for additional nuclear transfer |
| 01/27/2005 | US20050022260 Genetically engineered avian for use as bioreactors in heterologous protein expression; animal model for disease |
| 01/27/2005 | US20050022259 Genetically engineered embryonic stem cells for use in prevention and treatment of cell proliferfative disorders; gene therapy |
| 01/27/2005 | US20050022258 Genetically determined mouse model of resistance to transplantable cancers |
| 01/27/2005 | US20050022257 Transgenic animals harboring appallele having swedish mutation |
| 01/27/2005 | US20050022256 Triple transgenic mouse model of alzheimer's disease |
| 01/27/2005 | US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/27/2005 | US20050019812 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019811 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019260 Animal model for allergy |
| 01/27/2005 | CA2525949A1 Transgenic cells expressing proteins involved in fatty acid biosynthesis |
| 01/26/2005 | EP1500702A1 APO-2LI and APO-3 apoptosis polypeptides from the TNFR1 familiy |
| 01/26/2005 | EP1500329A2 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 01/26/2005 | EP1499897A1 Diagnostic and therapeutic use of ensadin-0255 gene and protein for neurodegenerative diseases |
| 01/26/2005 | EP1499734A2 Process of producing environmentally safe transgenic organisms |
| 01/26/2005 | EP1499718A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/26/2005 | EP1499350A2 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 01/26/2005 | EP1499340A2 Proteins involved in the regulation of energy homeostasis |
| 01/26/2005 | EP1499327A2 Beta -amyloid peptide-binding proteins and polynucleotides encoding the same |
| 01/26/2005 | EP1499284A1 Biologically active compounds for the modification of bodily odours |
| 01/26/2005 | EP1499182A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression |
| 01/26/2005 | EP1499180A2 Cancer models |
| 01/26/2005 | EP1438331A4 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 01/26/2005 | EP1383889A4 Modified organs and cells for xenotransplantation |
| 01/26/2005 | EP1294931A4 Screening methods for gram-positive enterococcal virulence factors |
| 01/26/2005 | EP1257167A4 Production of mammals which produce progeny of a single sex |
| 01/26/2005 | EP0579758B1 Parathyroid hormone receptor and dna encoding same |
| 01/26/2005 | CN2673094Y Chinese forest frog southern cultivating canopy |
| 01/26/2005 | CN1571836A Human antibodies specific for interleukin 15 (IL-15) |
| 01/26/2005 | CN1571633A Mycoplasma bovis challenge model and methods for administering M.bovis and methods for inducing pneumonic lung lesions |
| 01/26/2005 | CN1568683A Bombyx mori rearing shack in field |
| 01/26/2005 | CN1568682A Method for outdoors cocooning of bombyx mori and special checker cocooning tool thereof |
| 01/26/2005 | CN1568681A Method for cultivating toad evildoers using traditional Chinese medicine |
| 01/26/2005 | CN1568680A Method and apparatus for classifying farm animal products by grade |
| 01/25/2005 | US6846799 Administering epidermal growth factor antagonist; blocking with antibody; chronic obstructive pulmonary disease |
| 01/25/2005 | US6846662 Vertebrate telomerase genes and proteins and uses thereof |
| 01/20/2005 | WO2005005619A1 Non-inbred embryonic stem cells having good developmental potential |
| 01/20/2005 | WO2005004611A1 Feed ration for finishing swine |
| 01/20/2005 | WO2005004592A2 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 01/20/2005 | WO2005004591A1 Treatment models and uses thereof |
| 01/20/2005 | WO2004093788A9 Desmoglein 4 is a novel gene involved in hair growth |
| 01/20/2005 | WO2004076648A9 Clinically relevant animal model of human breast cancer and vegf involement in desmoplastic response. |
| 01/20/2005 | US20050015825 Method of preparing eggs for nuclear transfer and uses thereof |
| 01/20/2005 | US20050015823 Screening methods employing fish model assessment of vision |
| 01/20/2005 | US20050015821 Sensin polypeptides, encoding nucleic acids, mutations, and methods of their identification and use |
| 01/20/2005 | US20050015820 Using transgenic mouse tissue as model for monitoring agents that affect appetite, energy expenditure and caloric and food intake; dietetics and weight gain |
| 01/20/2005 | US20050015819 Generating animal model with enhanced tau protein expression; for use as tool in treatment and prevention of neurodegenerative diseases |
| 01/20/2005 | US20050014834 Selective anesthetic agents and methods of identifying the same |
| 01/20/2005 | US20050014821 Compounds and methods for treating neurodegenerative disorders |
| 01/20/2005 | US20050014251 Production fo eukaryotic proteins and nucleic acid molecules in c. elegans |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | US20050014150 Screening eukaryotic messenger RNA sequences and identifying internal ribosome entry site (IRES) elements for use in cap-independent expression of foreign genes in eukaryotic cells; enhancing in vitro translation heterologous |
| 01/20/2005 | DE10328102A1 Growing flesh flies on plant-based substrates, used to produce larvae and pupae for promotion of wound healing, eliminates risk of transferring pathogens associated with use of animal-based nutrient media |
| 01/20/2005 | CA2534090A1 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 01/20/2005 | CA2530210A1 Non-inbred embryonic stem cells having good developmental potential |
| 01/20/2005 | CA2524771A1 Non-human animals expressing heterologous complement receptor type 1 (cr1) molecules on erythrocytes and uses therefor |
| 01/19/2005 | EP1498479A2 Non-myeloablative tolerogenic treatment |
| 01/19/2005 | EP1498136A2 Non-myeloablative tolerogenic treatment |
| 01/19/2005 | EP1497661A1 Diagnostic and therapeutic use of ensadin-0477 gene and protein for neurodegenerative diseases |
| 01/19/2005 | EP1497643A1 Enclosed aquacultural systems for production of purified recombinant proteins |
| 01/19/2005 | EP1497460A1 Diagnostic and therapeutic use of ensadin-0138 gene and protein for neurodegenerative diseases |
| 01/19/2005 | EP1497427A2 Helicokinin-receptor from insects |
| 01/19/2005 | EP1497419A1 Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof |
| 01/19/2005 | EP1497418A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 01/19/2005 | EP1497413A1 Methods for producing immortalised antibodies-secreting cells |
| 01/19/2005 | EP1497315A2 Nucleic acid-associated proteins |
| 01/19/2005 | EP1496886A1 Knockout mice and their use |
| 01/19/2005 | CN1568373A RNA interference mediating small rna molecules |
| 01/19/2005 | CN1568366A Methods for injecting avian eggs |
| 01/19/2005 | CN1566947A Primate animal model for SARS related coronary virus, its construction method and use thereof |
| 01/19/2005 | CN1565176A Chicken and duck breeding technology using fly maggot |
| 01/19/2005 | CN1184961C Use of EGF-R antagonists in preparing drug |
| 01/19/2005 | CN1184880C Method for scaled breeding cattail mite and application in biological preventing and controlling pest-insect |
| 01/19/2005 | CN1184879C Scaled breeding for semanotus bifasciatus and application in biological preventing and controlling pest-insect |
| 01/18/2005 | US6844483 Screening activity of hypotensive agents; obtain mammal, administer hypotensive agent, monitor adjustments in hypertension |
| 01/18/2005 | US6844175 Methods of inhibition using glycosyl sulfotransferase-3 |
| 01/13/2005 | WO2005003786A2 Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders |
| 01/13/2005 | WO2005003359A1 Method and system of constructing transgenic organism |
| 01/13/2005 | WO2005003342A1 Method of preparing transgenic organism with use of methylation and system therefor |
| 01/13/2005 | WO2005002614A1 Methods and compositions for treating disorders of the extracellular matrix |
| 01/13/2005 | US20050010967 Animal model comprising nucleotide sequences coding small conductance calcium-activated potassium (SK) channel protein for use in identifying modulators for treatment of behavioral disorders and nervous system disorders |
| 01/13/2005 | US20050010966 Using nuclear transplantion of somatic cell genome to transform and generate cloned non-human mammal; bioengineering; tissue engineering |
| 01/13/2005 | US20050010965 Method for producing tissue engineered meat for consumption |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |